Ca. Bradham et al., REPERFUSION AFTER LIVER-TRANSPLANTATION IN RATS DIFFERENTIALLY ACTIVATES THE MITOGEN-ACTIVATED PROTEIN-KINASES, Hepatology, 25(5), 1997, pp. 1128-1135
The injury resulting from cold ischemia and warm reperfusion during li
ver transplantation is a major clinical problem that limits graft succ
ess, Kupffer cell activation plays a pivotal role in reperfusion injur
y, and Kupffer cell products, including free radicals and tumor necros
is factor alpha (TNF-alpha), are implicated as damaging agents, Howeve
r, the second messengers and signaling pathways that are activated by
the stress of hepatic ischemia/reperfusion remain unknown. The purpose
of this study is to assess the activation of the three known vertebra
te mitogen activated protein kinase (MAPKs) and the activating protein
1 (AP-1) transcription factor in response to ischemia and reperfusion
in the transplanted rat liver, There was a potent, sustained inductio
n of c-jun N-terminal kinase (JNK), but not of the related MAPKs extra
cellular signal-regulated kinases (ERK) or p38, upon reperfusion after
transplantation. TNF-alpha messenger RNA (mRNA) levels and transcript
ion factors AP-1 and nuclear factor-kappa B (NF-kappa B) were induced
in the liver after 60 minutes of reperfusion, Finally, there was an el
evation of ceramide, but not diacylglycerol or sphingosine, in the tra
nsplanted liver, Ceramide is a second messenger generated by TNF-alpha
treatment and is an activator of JNK. Because JNK activation preceded
the elevations in ceramide and TNF-alpha mRNA, these results suggest
that increased hepatic TNF-alpha and ceramide may perpetuate JNK induc
tion, but that they are not the initiating signals of JNK activation d
uring reperfusion injury in the transplanted liver.